All stock lists
Healthpeak Properties, Inc. (New York Stock Exchange:DOC)
US · Delayed Price · Currency is USD
Also listed: PEAKReal Estate · REIT - Healthcare Facilities
20.12-0.05 (-0.25%)
Market cap
$13.9B
Insider Score
Health Score
Analyst consensus
Listed since
May 23, 1985
Website
Insider Score
––Not scored
DOC Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
DOC analyst forecast
DOC analyst consensus
Hold8 ratings
Buy 2 Hold 6 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
DOC 12-month price target
$21.00+4.4% upsideaverage of 1 firm
$21.00High
$21.00Low
DOC ratings mix, last 12 months
Buy Hold Sell
Best analysts covering DOC
- Morgan Stanley100%success rate · +28.8% avg return · 1 call
- Mizuho50%success rate · -3.2% avg return · 4 calls
- Baird25%success rate · +2.4% avg return · 4 calls
- RBC Capital20%success rate · -15.7% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
DOC analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Cantor Fitzgerald | Neutral | — | — | Reiterated | 2026-11-04 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-19 |
| — | UBS | Neutral | — | — | Reiterated | 2026-10-13 |
| Barclays | Equal Weight | $21.00 | +10.8% | Reiterated | 2026-10-13 | |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-09-21 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-08-31 |
| — | Baird | Outperform | — | — | Reiterated | 2026-08-13 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-08-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-10 |
| — | Cantor Fitzgerald | Neutral | — | — | Reiterated | 2026-08-06 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-07-15 |
| — | UBS | Neutral | — | — | Reiterated | 2026-07-08 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2026-07-07 |
| — | Mizuho | Outperform | — | — | Reiterated | 2026-07-06 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-06-24 |
| — | BMO Capital | Outperform | — | — | Reiterated | 2026-06-15 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2026-06-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-06-01 |
| — | Scotiabank | Sector Perform | — | — | Reiterated | 2026-05-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-22 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-14 |
| — | Baird | Outperform | — | — | Reiterated | 2026-05-13 |
| — | UBS | Neutral | — | — | Reiterated | 2026-05-13 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-05-12 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-04-28 |
| — | Baird | Outperform | — | — | Reiterated | 2026-04-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-04-01 |
| — | Argus Research | Hold | — | — | Downgraded | 2026-02-05 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-04 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-02 |
| — | Jefferies | Hold | — | — | Downgraded | 2025-12-16 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-12-15 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-25 |
| — | Baird | Outperform | — | — | Reiterated | 2025-11-12 |
| — | Raymond James | Outperform | — | — | Upgraded | 2025-09-15 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-08-27 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-08-22 |
| — | Deutsche Bank | Hold | — | — | Downgraded | 2025-08-20 |
| — | Baird | Outperform | — | — | Reiterated | 2025-07-30 |
| — | Scotiabank | Sector Perform | — | — | Downgraded | 2025-07-29 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-06-02 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-05-12 |
| — | Baird | Outperform | — | — | Reiterated | 2025-04-29 |
| — | Argus Research | Buy | — | — | Reiterated | 2025-04-29 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-04-28 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-04-28 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-04-11 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-02-28 |
| — | Wedbush | Outperform | — | — | Reiterated | 2025-02-14 |
| — | Baird | Outperform | — | — | Reiterated | 2025-02-11 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-12-10 |
| — | Mizuho | Outperform | — | — | Reiterated | 2024-12-05 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-11-04 |
| — | Baird | Outperform | — | — | Reiterated | 2024-10-30 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-07-30 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-07-29 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-05-16 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-05-16 |
| — | Wedbush | Outperform | — | — | Upgraded | 2024-05-03 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-04-10 |
DOC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-02 | 0.45 | 0.16 | $691.6M | $704.8M |
| 2026-05-05 | 0.05 | 0.28 | $694.6M | $738.8M |
| 2026-08-04 | 0.03 | 0.08 | $725.6M | $749.8M |
| 2026-11-02 | 0.06 | 0.02 | $739.2M | $820.9M |
| 2027-02-01Upcoming | 0.04 | — | $749.9M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.